机构风向标 | 罗欣药业(002793)2025年三季度已披露持仓机构仅7家

Core Insights - 罗欣药业 reported its Q3 2025 financial results, highlighting significant institutional investor interest with a total of 4.35 billion shares held, representing 39.96% of the company's total equity [1] Institutional Holdings - As of October 27, 2025, seven institutional investors disclosed their holdings in 罗欣药业, with a combined ownership increase of 0.80 percentage points from the previous quarter [1] - Major institutional investors include 山东罗欣控股有限公司, 上海中珏私募基金管理有限公司, ALLY BRIDGE FLAGSHIP LX (HK) LIMITED, and others [1] Public Fund Activity - In this reporting period, 22 public funds were disclosed, including 富国稳健增长混合A, 华宝创新优选混合, and others, indicating continued interest from public investment vehicles [1] Foreign Investment - One foreign fund, 香港中央结算有限公司, increased its holdings by 1.39% compared to the previous period, reflecting a positive sentiment from foreign investors [1]